Indian Drug Schedules
NDPS Act Drugs in India: Narcotic Drugs and Psychotropic Substances Act, 1985
Comprehensive guide to the NDPS Act, 1985 -- which drugs are covered, the quantity-based penalty structure, medical use provisions, and relevance to NEET PG examinations.
MedNext Academy | 5 min read
NDPS Act Drugs in India: Narcotic Drugs and Psychotropic Substances Act, 1985
Comprehensive guide to the NDPS Act, 1985 -- which drugs are covered, the quantity-based penalty structure, medical use provisions, and relevance to NEET PG examinations.
What Is the NDPS Act?
The Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) is the principal legislation in India governing the production, manufacture, possession, sale, transport, consumption and use of narcotic drugs and psychotropic substances. Unlike the Drugs and Cosmetics Act, 1940 (which regulates drugs in the healthcare context), the NDPS Act operates as a criminal law with severe penalties, including lengthy imprisonment and heavy fines.
The Act was enacted to fulfill India's obligations under three United Nations conventions: the Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (1988). The Narcotics Control Bureau (NCB), under the Ministry of Home Affairs, is the primary enforcement agency.
Legal Framework and Classification
The NDPS Act classifies controlled substances into categories based on three schedules appended to the Act:
Narcotic Drugs include opium, morphine, heroin (diacetylmorphine), cocaine, cannabis (ganja, charas, bhang in certain forms), codeine and their derivatives. Psychotropic Substances include amphetamines, methaqualone, LSD (lysergic acid diethylamide), MDMA (ecstasy), mescaline, psilocybin, and several benzodiazepines and barbiturates.
The Act defines three quantity thresholds that determine the severity of penalties: Small Quantity, quantities between small and commercial, and Commercial Quantity. These thresholds vary for each substance and are specified in the notification issued under the Act.
Key Drugs Covered Under the NDPS Act
- Morphine -- narcotic analgesic, small quantity 5 g, commercial quantity 250 g
- Heroin (diacetylmorphine) -- no legitimate medical use in India, small quantity 5 g, commercial quantity 250 g
- Cocaine -- local anaesthetic historically, now primarily illicit, small quantity 2 g, commercial quantity 100 g
- Cannabis (ganja) -- small quantity 1 kg, commercial quantity 20 kg
- Charas (cannabis resin) -- small quantity 100 g, commercial quantity 1 kg
- Opium -- small quantity 25 g, commercial quantity 2.5 kg
- Codeine -- opioid, used medicinally, controlled under NDPS for non-medical use
- Methadone -- used in opioid substitution therapy, controlled substance
- Buprenorphine -- partial opioid agonist, used in de-addiction
- Fentanyl -- potent synthetic opioid, increasingly controlled due to global fentanyl crisis
- Amphetamine -- CNS stimulant, psychotropic substance
- Methamphetamine -- CNS stimulant, psychotropic substance
- LSD -- hallucinogen, psychotropic substance
- MDMA (Ecstasy) -- psychotropic substance
- Ketamine -- dissociative anaesthetic, added to NDPS Act control in specific states
Penalty Structure
The NDPS Act uses a three-tier penalty system based on quantity:
For Small Quantity: Imprisonment up to one year, or fine up to INR 10,000, or both. For quantities between small and commercial: Imprisonment up to 10 years and fine up to INR 1,00,000 (one lakh). For Commercial Quantity: Imprisonment of 10 to 20 years and fine of INR 1,00,000 to 2,00,000 (one to two lakh). Repeat offences for commercial quantity can attract the death penalty under Section 31A, though this has rarely been applied.
The 2014 amendment to the NDPS Act was significant -- it rationalised the penalty structure by introducing the small-quantity threshold, reducing harsh mandatory minimums for personal-use quantities while maintaining severe penalties for trafficking.
Medical Use and Essential Narcotic Drugs
The NDPS Act recognises that narcotic drugs have essential medical uses, particularly for pain management and palliative care. Section 9 empowers the Central Government to permit, regulate and control the medical and scientific use of narcotic drugs and psychotropic substances.
Under the amended NDPS Act and state NDPS Rules, medical use of morphine and other opioids is permitted through recognised medical institutions, registered hospitals, and authorised pharmacies. Each state has its own procedures for obtaining licences to stock and dispense NDPS substances for medical purposes.
However, India has historically had extremely poor access to morphine for pain relief, with estimated medical opioid consumption among the lowest in the world. This has been attributed to overly complex licensing procedures and fear of NDPS penalties among healthcare providers. Amendments in 2014 aimed to simplify access for palliative care.
Record-Keeping and Compliance
Any entity authorised to handle NDPS substances must maintain detailed records including the quantity received with source details, quantity consumed or dispensed with patient/purpose details, running balance, disposal records for expired stock, and annual returns submitted to the state drug controller and the Narcotics Commissioner.
Hospitals and pharmacies must submit these returns by specified deadlines. Failure to maintain records or submit returns is itself a criminal offence under the NDPS Act, regardless of whether any diversion has occurred.
Relevance to NEET PG and Medical Examinations
The NDPS Act is tested extensively in forensic medicine and toxicology papers for NEET PG, INI-CET and FMGE. Key exam-relevant topics include the three-tier penalty structure (small, intermediate, commercial quantities), specific quantity thresholds for major substances (morphine, heroin, cannabis, cocaine), the year of enactment (1985) and major amendments (2001, 2014), the role of the Narcotics Control Bureau, the distinction between NDPS Act and Drugs and Cosmetics Act controls, provisions for medical use of narcotic drugs, and Section 31A (death penalty for repeat offenders in commercial quantity cases).
Questions often test the exact quantity thresholds and corresponding penalties, making this a topic where memorisation of specific numbers is required.
Recent Updates and Changes
The 2014 amendment was the most significant update, rationalising penalties and improving access to essential narcotic drugs for medical purposes. Key changes included the introduction of the small-quantity category, simplification of state-level licensing for medical opioid use, and establishment of the NDPS Consultative Committee.
Recent enforcement trends include increased attention to synthetic drugs and new psychoactive substances, growing concern about fentanyl analogues entering India, and enhanced use of technology for tracking licit narcotic drug supply chains. The government has also been working on aligning India's controlled substance schedules with the latest WHO Expert Committee recommendations.
Regulatory governance
**Authority:** Central Drugs Standard Control Organisation (CDSCO), Government of India. **Legislation:** Drugs and Cosmetics Act, 1940 and Rules, 1945 (as amended). **Publication state:** Awaiting review. **Correction:** Report errors at support@mednext.academy.
Frequently Asked Questions
What is the difference between the NDPS Act and the Drugs and Cosmetics Act?
The Drugs and Cosmetics Act, 1940 regulates the manufacture, sale and distribution of drugs for medical purposes, including scheduling them by prescription requirements (H, H1, X, G). The NDPS Act, 1985 is a criminal law that prohibits and penalises the production, possession, sale and consumption of narcotic drugs and psychotropic substances outside of authorised medical and scientific channels. A substance can be controlled under both laws simultaneously.
What are the quantity thresholds under the NDPS Act?
The NDPS Act defines three tiers: Small Quantity (lowest penalties, typically for personal use), quantities between small and commercial (moderate penalties), and Commercial Quantity (severest penalties including 10-20 years imprisonment). The exact thresholds vary by substance -- for example, heroin has a small quantity threshold of 5 grams and a commercial quantity threshold of 250 grams.
Can doctors legally prescribe morphine in India?
Yes. Morphine and other opioid analgesics can be prescribed by doctors for legitimate medical purposes, particularly pain management and palliative care. However, the prescribing institution must have the appropriate state-level licence under the NDPS Act, and detailed records must be maintained. The 2014 amendment simplified these licensing requirements.
Is cannabis legal in India under the NDPS Act?
The NDPS Act prohibits cannabis resin (charas) and the flowering or fruiting tops of the cannabis plant (ganja). However, bhang -- made from the leaves of the cannabis plant -- is not explicitly covered by the NDPS Act and is regulated by individual state excise laws. Some states permit bhang, while others restrict it.
What is Section 31A of the NDPS Act?
Section 31A provides for the death penalty for repeat offenders convicted of offences involving commercial quantities of certain narcotic drugs and psychotropic substances. It applies to second or subsequent convictions. While this provision exists in law, the death penalty under NDPS has rarely been imposed by Indian courts.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
FormularyDrug Formulary
Individual drug profiles with Indian brands, dosing and exam pearls.
Subject HubPharmacology Hub
All pharmacology resources in one place.
Test your drug schedule knowledge
Test your knowledge of Indian drug regulation with targeted MCQs on schedules, prescribing rules and the Drugs and Cosmetics Act.
Test drug schedule knowledge